Prosecution Insights
Prosecution Insights
3 pending office actions • 3 art units • 3 examiners • 2 of 3 (67%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| §102 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MULDER, SCOTT EVAN | 1 | 30.8% | +63.9% |
| DUFFY, BRADLEY | 1 | 54.4% | +45.4% |
| ZINGARELLI, SANDRA | 1 | 8.0% | +45.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17623398 | A TRUNCATED VON WILLEBRAND FACTOR (VWF) FOR INCREASING THE IN VITRO STABILITY OF COAGULATION FACTOR VIII | ZINGARELLI, SANDRA | 23d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17775704 | POLYPEPTIDES FOR INDUCING TOLERANCE TO FACTOR VIII | MULDER, SCOTT EVAN | 113d overdue |
| 17623398 | A TRUNCATED VON WILLEBRAND FACTOR (VWF) FOR INCREASING THE IN VITRO STABILITY OF COAGULATION FACTOR VIII | ZINGARELLI, SANDRA | 23d overdue |
| 17641520 | RECOMBINANT IgG Fc MULTIMERS FOR THE TREATMENT OF IMMUNE COMPLEX-MEDIATED KIDNEY DISORDERS | DUFFY, BRADLEY | 16d overdue |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| 1643 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17775704 | POLYPEPTIDES FOR INDUCING TOLERANCE TO FACTOR VIII | MULDER, SCOTT EVAN | 1656 | §103 | Non-Final OA | 113d overdue | AI Ready | May 10, 2022 |
| 17641520 | RECOMBINANT IgG Fc MULTIMERS FOR THE TREATMENT OF IMMUNE COMPLEX-MEDIATED KIDNEY DISORDERS | DUFFY, BRADLEY | 1643 | §102 | Final Rejection | 16d overdue | AI Ready | Mar 09, 2022 |
| 17623398 | A TRUNCATED VON WILLEBRAND FACTOR (VWF) FOR INCREASING THE IN VITRO STABILITY OF COAGULATION FACTOR VIII | ZINGARELLI, SANDRA | 1653 | §103 | Non-Final OA | 23d overdue | Pending | Dec 28, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial